Parallel Advisors
IOVA icon

Parallel Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

Parallel Advisors’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.92K Hold
332
– – ﹤0.01% 3375
2026
Q2 		$1.38K Hold
332
– – ﹤0.01% 3614
2026
Q1 		$1.16K Buy
+332
New +$1.06K ﹤0.01% 3509
2025
Q3 		– Sell
-86
Closed -$148 – 3625
2025
Q2 		$148 Hold
86
– – ﹤0.01% 3436
2025
Q1 		$286 Sell
86
-251
-74% -$1.29K ﹤0.01% 3334
2024
Q4 		$2.49K Buy
337
+153
+83% +$1.42K ﹤0.01% 2895
2024
Q3 		$1.73K Sell
184
-129
-41% -$1.22K ﹤0.01% 2919
2024
Q2 		$2.51K Buy
313
+205
+190% +$2.2K ﹤0.01% 2743
2024
Q1 		$1.6K Hold
108
– – ﹤0.01% 2857
2023
Q4 		$878 Sell
108
-477
-82% -$2.5K ﹤0.01% 2965
2023
Q3 		$2.66K Buy
585
+384
+191% +$2.51K ﹤0.01% 2726
2023
Q2 		$1.42K Sell
201
-35
-15% -$251 ﹤0.01% 2850
2023
Q1 		$1.44K Buy
236
+16
+7% +$110 ﹤0.01% 2864
2022
Q4 		$1.41K Sell
220
-316
-59% -$2.47K ﹤0.01% 2808
2022
Q3 		$5K Buy
536
+26
+5% +$300 ﹤0.01% 2299
2022
Q2 		$6K Buy
510
+252
+98% +$3.3K ﹤0.01% 2184
2022
Q1 		$4K Sell
258
-395
-60% -$6.11K ﹤0.01% 2375
2021
Q4 		$12K Sell
653
-37
-5% -$815 ﹤0.01% 2031
2021
Q3 		$17K Buy
690
+334
+94% +$7.87K ﹤0.01% 1824
2021
Q2 		$9K Buy
356
+277
+351% +$7.2K ﹤0.01% 2049
2021
Q1 		$3K Buy
79
+34
+76% +$1.41K ﹤0.01% 2375
2020
Q4 		$2K Hold
45
– – ﹤0.01% 2316
2020
Q3 		$1K Hold
45
– – ﹤0.01% 2447
2020
Q2 		$1K Buy
+45
New +$1.48K ﹤0.01% 2329

Other funds holding IOVA

Mirador Capital Partners
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Raiffeisen Bank International
Raiffeisen Bank International Vienna, Austria $8.69B AUM 38.11% 1-Year Est. Return
Sugar Maple Asset Management
Sugar Maple Asset Management Sister Bay, Wisconsin $175M AUM 16.33% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

Parallel Advisors's IOVA Position: Q3 2026 in Review

Parallel Advisors held its Iovance Biotherapeutics (IOVA) position steady in Q3 2026 at 332 shares worth $4.92K. The position accounts for ﹤0.01% of the portfolio, ranked #3375.

Parallel Advisors first reported a position in IOVA in Q2 2020 and has held it in 24 quarters since. The position peaked at $17K in Q3 2021. 89 funds tracked by Wall St. Rank hold IOVA as of Q3 2026.

  • Parallel Advisors held 332 shares of Iovance Biotherapeutics worth $4.92K as of Q3 2026.
  • Parallel Advisors left its Iovance Biotherapeutics share count unchanged in Q3 2026.
  • Iovance Biotherapeutics made up ﹤0.01% of Parallel Advisors's portfolio in Q3 2026, its #3375 holding.
  • Parallel Advisors first reported a position in Iovance Biotherapeutics in Q2 2020 and has held it in 24 quarters since.
  • Parallel Advisors's Iovance Biotherapeutics position peaked at $17K in Q3 2021.
  • 89 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2026.

Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.